U.S. markets open in 46 minutes
  • S&P Futures

    4,113.75
    -5.75 (-0.14%)
     
  • Dow Futures

    33,638.00
    -44.00 (-0.13%)
     
  • Nasdaq Futures

    13,793.75
    -35.75 (-0.26%)
     
  • Russell 2000 Futures

    2,237.30
    -1.90 (-0.08%)
     
  • Crude Oil

    60.10
    +0.78 (+1.31%)
     
  • Gold

    1,740.80
    -4.00 (-0.23%)
     
  • Silver

    25.17
    -0.15 (-0.59%)
     
  • EUR/USD

    1.1920
    +0.0016 (+0.13%)
     
  • 10-Yr Bond

    1.6680
    +0.0020 (+0.12%)
     
  • Vix

    17.26
    +0.31 (+1.83%)
     
  • GBP/USD

    1.3772
    +0.0066 (+0.48%)
     
  • USD/JPY

    109.2780
    -0.3720 (-0.34%)
     
  • BTC-USD

    60,538.96
    +752.95 (+1.26%)
     
  • CMC Crypto 200

    1,293.85
    +66.31 (+5.40%)
     
  • FTSE 100

    6,897.71
    -18.04 (-0.26%)
     
  • Nikkei 225

    29,538.73
    -229.33 (-0.77%)
     

Alkermes to Take Part in SVB Leerink 10th Annual Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

DUBLIN, Feb. 18, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the SVB Leerink Global Healthcare Conference on Wednesday, Feb. 24, 2021 at 9:20 a.m. ET (2:20 p.m. GMT). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

Alkermes plc Logo (PRNewsfoto/Alkermes plc)
Alkermes plc Logo (PRNewsfoto/Alkermes plc)
Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-take-part-in-svb-leerink-10th-annual-global-healthcare-conference-301231128.html

SOURCE Alkermes plc